Arte Ventures

Arte Ventures is a venture capital firm based in San Francisco that specializes in early-stage investments within the healthcare and life sciences sectors. The firm is particularly noted for its deep expertise and strategic focus on metabolic and liver diseases, including nonalcoholic steatohepatitis (NASH). Arte Ventures identifies and supports innovative companies developing transformative therapies, medical devices, and digital health solutions, leveraging a team of seasoned professionals with backgrounds in clinical development and regulatory affairs. Its portfolio includes several high-profile biotechnology companies that have reached advanced clinical stages or public markets.